High levels of soluble tumor necrosis factor superfamily receptors in patients with hepatitis C virus infection and lymphoproliferative disorders

Journal of Hepatology

Volumn 34, Issue 5, 2001, Pages 723-729

  Realdon, Stefano ^a   Pontisso, Patrizia ^a   Adami, Fausto ^a   Trentin, Livio ^a   Noventa, Franco ^a   Ferrari, Alessia ^a   Migliorato, Irene ^a   Gatta, Angelo ^a   Alberti, Alfredo ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

B cell non Hodgkin's lymphoma; Cryoglobulinemia; Hepatitis C virus; Soluble tumor necrosis factor receptors

Indexed keywords

TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CHRONIC HEPATITIS; CONTROLLED STUDY; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIRUS INFECTION;

ADULT; AGED; ANTIGENS, CD95; CRYOGLOBULINEMIA; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, NON-HODGKIN; LYMPHOMA, SMALL LYMPHOCYTIC; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; SOLUBILITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035000983     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)00063-5     Document Type: Article

References (47)

1. Alter M.J., Margolis H.S., Krawcynski K., Judson F.N., Mares A., Alexander W.J., et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med. 327:1992;1899-1905.
2. Marcellin P., Descamps V., Martinot-Peignoux M., Larzul D., Xu L., Boyer N., et al. Cryoglobulinemia with vasculitis associated with hepatitis C virus infection. Gastroenterology. 104:1993;272-277.
3. Lunel F. Hepatitis C virus and autoimmunity: fortuitous association or reality? Gastroenterology. 107:1994;1550-1555.
4. Silvestri F., Pipan C., Barillari G., Zaja F., Fanin R., Infanti R., et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood. 87:1996;4296-4301.
5. Agnello V., Chung R.T., Kaplan L.M. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med. 327:1992;1490-1495.
6. Rasul I., Shepherd F.A., Kamel-Reid S., Krajden M., Pantalony D., Heathcote E.J. Detection of occult low-grade B-cell non-Hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia. Hepatology. 29:1999;543-547.
7. Ferri C., Monti M., La Civita L., Longobardo G., Greco F., Pasero G., et al. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood. 82:1993;3701-3704.
8. Gabrielli A., Manzin A., Candela M., Caniglia M.L., Paolucci S., Danieli M.G., et al. Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinemia. Clin Exp Immunol. 97:1994;87-93.
9. Zignego A.L., Ferri C., Giannini C., La Civita L., Careccia G., Longobardo G., et al. Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role. Arch Virol. 142:1997;545-555.
10. Sansonno D., de Vita S., Iacobelli A.R., Cornacchiulo V., Boiocchi M., Dammacco F. Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. J Immunol. 160:1998;3594-3601.
11. Pileri P., Uematsu Y., Campagnoli S., Galli G., Falugi F., Petracca R., et al. Binding of hepatitis C virus to CD81. Science. 282:1998;938-940.
12. Ray B.R., Meyer K., Ray R. Suppression of apoptotic cell death by hepatitis C virus core protein. Virology. 226:1996;176-182.
13. Ray R.B., Lagging K., Meyer K., Ray R. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol. 70:1996;4438-4443.
14. Chang J., Yang S.H., Cho Y.G., Hwang S.V., Hahn Y.S., Sung Y.C. Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogene. J Virol. 72:1998;3060-3065.
15. Sakamuro D., Frukawa T., Takegami T. Hepatitis C virus non-structural protein NS3 transforms NIH 3T3 cells. J Virol. 69:1995;3893-3898.
16. Gale M. Jr, Kwieciszewski B., Dossett M., Nakao H., Katze M.G. Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase. J Virol. 73:1999;6506-6516.
17. Nagata S., Golstein P. The Fas death factor. Science. 267:1995;1449-1455.
18. Armitage R.J. Tumor necrosis factor receptor superfamily members and their ligands. Curr Opin Immunol. 6:1994;407-413.
19. Ruberti G., Cascino I., Papoff G., Eramo A. Fas splicing variants and their effect on apoptosis. Adv Exp Med Biol. 406:1996;125-134.
20. Gruss H.J., Dower S. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood. 85:1995;3378-3404.
21. Waage A., Liabakk N., Lien E., Lamvik J., Espevik T. p55 and p75 tumor necrosis factor receptors in patients with chronic lymphocytic leukemia. Blood. 80:1992;2577-2583.
22. Cheng J., Zhou T., Liu C., Shapiro J.P., Brauer M.J., Kiefer M.C., et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science. 263:1994;1759-1762.
23. Lenardo M.J. Fas and the art of lymphocyte maintenance. J Exp Med. 183:1996;721-724.
24. Calvano S.E., Van Der Poll T., Coyle S.M., Barie P.S., Moldawer L.L., Lowry S.F. Monocyte tumor necrosis factor receptor levels as a predictor of risk in human sepsis. Arch Surg. 131:1996;434-437.
25. Bilello J.A., Stellrecht K., Drusano G.L., Stein D.S. Soluble tumor necrosis factor-alpha receptor type II (sTNF alpha RII) correlates with human immunodeficiency virus (HIV) RNA copy number in HIV-infected patients. J Infect Dis. 173:1996;464-467.
26. Kalinkovich A., Livshits G., Engelmann H., Harpaz N., Burstein R., Kaminsky M. Soluble tumor necrosis factor receptors (sTNF-R) and HIV infection: correlation to CD8+ lymphocytes. Clin Exp Immunol. 93:1993;350-355.
27. Iio S., Hayashi N., Mita E., Ueda K., Mochizuki K., Hiramatsu N., et al. Serum levels of soluble Fas antigen in chronic hepatitis C patients. J Hepatol. 29:1998;517-523.
28. Zylberberg H., Rimaniol A.C., Pol S., Masson A., De Groote D., Berthelot P., et al. Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity. J Hepatol. 30:1999;185-191.
29. Van Zee K.J., Kohno T., Fischer E., Rock C.S., Moldawer L.L., Lowry S.F. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci USA. 89:1992;4845-4849.
30. Seckinger P., Isaaz S., Dayer J.M. Purification and biologic characterization of specific tumor necrosis factor alpha inhibitor. J Biol Chem. 264:1989;11966-11973.
31. Pontisso P., Ruvoletto M.G., Fattovich G., Chemello L., Gallorini A., Ruol A., et al. Clinical and virological profiles in patients with multiple hepatitis virus infection. Gastroenterology. 105:1993;1529-1533.
32. Pontisso P., Gerotto M., Ruvoletto M.G., Fattovich G., Chemello L., Tisminetzky S., et al. Hepatitis C genotypes in patients with dual hepatitis B and C virus infection. J Med Virol. 48:1996;157-160.
33. Desmet V.J., Gerber M., Hoofnagle J.H., Manns M., Scheuer P.S. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 19:1994;1513-1520.
34. Zignego A.L., Ferri C., Giannini C., Monti M., La Civita L., Careccia G., et al. Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med. 124:1996;31-34.
35. Pozzato G., Mazzaro C., Crovatto M., Modolo M.L., Ceselli S., Mazzi G., et al. Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood. 84:1994;3047-3053.
36. Agnello V. The aetiology of mixed cryoglobulinemia associated with HCV infection. Scand J Immunol. 42:1995;179-184.
37. Monteverde A., Rivano M.T., Allegra G.C., Monteverde A.L., Zingrossi P., Baglioni P., et al. Essential mixed cryoglobulinemia type II: a manifestation of a low-grade malignant lymphoma? Acta Haematol. 79:1998;20-26.
38. Muratori L., Gibellini D., Lenzi M., Cataleta M., Muratori P., Morelli M.C., et al. Quantification of hepatitis C virus-infected peripheral blood mononuclear cells by in situ reverse transcriptase-polymerase chain reaction. Blood. 88:1996;2768-2774.
39. Ellis M., Rathaus M., Amiel A., Manor Y., Klein A., Lishner M. Monoclonal lymphocyte proliferation and blc-2 rearrangement in essential mixed cryoglobulinemia. Eur J Clin Invest. 25:1995;833-837.
40. Zignego A.L., Giannelli F., Marrocchi M.E., Giannini C., Gentilini P., Innocenti F., et al. Frequency of bcl-2 rearrangement in patients with mixed cryoglobulinemia and HCV-positive liver disease patients. Clin Exp Rheumatol. 15:1997;711-712.
41. Smith C.A., Davis T., Wignall J.M., Din W.S., Farrah T., Upton C., et al. T2 open reading frame from the shope fibroma virus encodes a soluble form of the TNF receptor. Biochem Biophys Res Commun. 176:1991;335-342.
42. Upton C., Macen J.L., Schreiber M., McFadden G. Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology. 184:1991;370-382.
43. Hu F-Q., Smith C.A., Pickup D.J. Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor. Virology. 204:1994;343-356.
44. Tilg H., Wilmer A., Vogel W., Herold M., Nolchen B., Judmaier G., et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology. 103:1992;264-274.
45. Larrea E., Garcia N., Qian C., Civeira M.P., Prieto J. Tumor necrosis factor α gene expression and the response to interferon in chronic hepatitis C. Hepatology. 23:1996;210-217.
46. Kallinowski B., Haseroth K., Marinos G., Hanck C., Stremmel W., Theilmann L., et al. Induction of tumor necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection. Clin Exp Immunol. 111:1998;269-277.
47. Ferenbach D.A., Haydon G.H., Rae F., Malcomson R.D., Harrison D.J. Alteration in mRNA levels of Fas splice variants in hepatitis C infected liver. J Pathol. 183:1997;299-317.